Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Apoteksgruppen i Järva Nr 1 AB
AB
Active
Org 5593001786
Rinkebysvängen 70 B, 163 74
Spånga
Retail sale of pharmaceutical products
· NACE 4773
Est. 2021
1 employees
Watchlist
Share
Sweden
/
Companies
/
Retail sale of pharmaceutical products
/
Apoteksgruppen i Järva Nr 1 AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
4M
8M
12M
16M
4M
2021
9M
2022
11M
2023
14M
2024
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
Income statement
SEK thousands
Item
2021
2022
2023
2024
Revenue
4 125
9 136
11 075
13 898
Staff expenses
—
−540
−843
−884
EBITDA
−473
−273
287
−5
Depreciation & amort.
−7
−21
−24
−27
EBIT
−480
−294
263
−32
Net financials
−12
−69
−95
−59
Profit before tax
−491
—
47
−141
Tax
−0
—
—
—
Net profit
−491
−363
47
−141
Balance sheet
SEK thousands
Item
2021
2022
2023
2024
Total assets
2 287
3 355
3 784
4 836
Equity
670
308
355
213
Long-term debt
0
—
—
—
Short-term debt
1 617
3 048
3 429
4 623
Total debt
1 617
3 048
3 429
4 623
Financial ratios
5-year trend
EBITDA margin
-0.0%
This company
15.8%
Market median
-100% vs market
2021
2024
Equity ratio
4.4%
This company
38.2%
Market median
-88% vs market
2021
2024
Return on equity
-66.1%
This company
18.4%
Market median
-459% vs market
2021
2024
Net profit margin
-1.0%
This company
8.1%
Market median
-112% vs market
2021
2024
Asset turnover
2.87×
This company
1.12×
Market median
+156% vs market
2021
2024
Debt / equity
21.71×
This company
0.62×
Market median
-3402% vs market
2021
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-02-01 – 2021-12-31
View
PDF
More on Apoteksgruppen i Järva Nr 1 AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network